Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure. Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
View Top Employees from Stem Cell TheranosticsWebsite | http://www.sctheranostics.com |
Revenue | $6 million |
Employees | 3 (3 on RocketReach) |
Founded | 2013 |
Address | 640 Galveston Drive, Redwood City, California 94063, US |
Phone | (608) 441-8376 |
Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, CardioModels - disease models custom designed for your needs, Science and Engineering, CardioScreens - tailored efficacy and toxicity screening program, Healthcare, Health Care, Discovery Partnerships - integrated partnership program to disco, Medical, Therapeutics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Stem Cell Theranostics employee's phone or email?
The Stem Cell Theranostics annual revenue was $6 million in 2024.
Rebecca Stanley is the Executive Director of Stem Cell Theranostics.
3 people are employed at Stem Cell Theranostics.
Stem Cell Theranostics is based in Redwood City, California.
The NAICS codes for Stem Cell Theranostics are [32, 325, 3254].
The SIC codes for Stem Cell Theranostics are [28, 283].